• Home
• Conference Coverage
• Event Calendar
• UroToday International Journal
• Advanced Search

Search    Display 5 10 15 20 25 30 50 results per page Results 1 - 9 of 9 << Start < Prev 1 Next > End >> European Urology - Optimisation of PDE5 Inhibitor Therapy in Men with Erectile Dysfunction: Converting “Non-Responders” into “Responders” Wednesday, 28 June 2006 Volume 50, Issue 1, Pages 31-33 (July 2006) The first line therapy for most men with erectile dysfunction is currently a phosphodiesterase type 5 (PDE5) inhibitor such as sildenafil, tadalafil, or vardenafil. read more European Urology - Salvage Techniques for Phosphodiesterase 5 Inhibitor Therapy: Purposeful but How Much? Wednesday, 28 June 2006 Volume 50, Issue 1, Pages 29-30 (July 2006) Several studies have confirmed that non-responders to the phosphodiesterase 5 (PDE5) inhibitor sildenafil for the treatment of erectile dysfunction (ED) can be “salvaged” with various strategies including reinstruction in using the medication and application of drug treatment optimisation techniques. read more European Urology - Open vs. Laparoscopic Radical Prostatectomy… and Laparoscopy is Better! Open vs. Laparoscopic Radical Prostatectomy… and Laparoscopy is Better! Wednesday, 28 June 2006 Volume 50, Issue 1, Pages 26-28 (July 2006) The article of Guazzoni et al. [1] focusses on an important question raised mainly by the advocates of open retropubic radical prostatectomy (RRP). read more European Urology - The Importance of Cyclooxygenase in Carcinogenesis: Is It a Therapeutic Target? Wednesday, 28 June 2006 Volume 50, Issue 1, Pages 23-25 (July 2006) Cyclooxygenase (COX) is a key enzyme in the prostanoid biosynthetic pathway, and COX-2, the inducible isoform of cyclooxygenase, is overexpressed in various cancers. read more European Urology - Search for Biomarkers of Aggressiveness in Bladder Cancer Wednesday, 28 June 2006 Volume 50, Issue 1, Pages 20-22 (July 2006) A noninvasive, highly accurate diagnostic test capable of predicting the probability of disease recurrence and progression has long been desired in the field of urologic oncology. read more European Urology - High Surgical Volume, High Quality, and Low Costs: A Perfect Combination: Is it Always Possible in Patients who need Radical Prostatectomy? Wednesday, 28 June 2006 Volume 50, Issue 1, Pages 17-19 (July 2006) Prostate cancer is becoming the most common malignancy in men and radical prostatectomy (RP) represents the most common form of treatment for early-stage disease [1]. read more European Urology - Female Sexual Dysfunction after Pelvic Surgery: Is There a Place for Nerve-Sparing Surgery? Wednesday, 28 June 2006 Volume 50, Issue 1, Pages 14-16 (July 2006) The review by Salonia et al. [1] raises an interesting new and neglected topic in urologic surgery—preservation of sexual function in women following urogynaecologic and oncologic pelvic surgical procedures. read more European Urology - Dendritic Cells for the Treatment of Metastatic Renal Cell Carcinoma: At a Low Ebb? Wednesday, 28 June 2006 Volume 50, Issue 1, Pages 11-13 (July 2006) 1. Dendritic cell vaccination and adoptive cellular therapy in the management of metastatic renal cell carcinoma: a smart concept for an old story. read more European Urology - Celebrating the 50th Volume of European Urology, "Your" Platinum Journal Wednesday, 28 June 2006 Volume 50, Issue 1, Pages 1-10 (July 2006) Having the opportunity to celebrate with you, our readers, the 50th volume of European Urology, “your” Platinum Journal is a major honour and pleasure for us. read more   << Start < Prev 1 Next > End >> Results 1 - 9 of 9

UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810 About The Editors | About Us | Contact Us | Report an Inaccuracy | Sponsorship Opportunities | Terms of Use Privacy Policy | © 2009 UroToday ® All Rights Reserved